These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

436 related items for PubMed ID: 10176832

  • 1. Medical devices; preemption of state product liability claims--FDA. Proposed rule.
    Fed Regist; 1997 Dec 12; 62(239):65384-8. PubMed ID: 10176832
    [Abstract] [Full Text] [Related]

  • 2. Medical devices; preemption of state product liability claims--FDA. Withdrawal of proposed rule.
    Fed Regist; 1998 Jul 24; 63(142):39789-90. PubMed ID: 10181516
    [Abstract] [Full Text] [Related]

  • 3. Medical devices; preemption of state product liability claims--FDA. Correction.
    Fed Regist; 1997 Dec 17; 62(242):66179. PubMed ID: 10179302
    [No Abstract] [Full Text] [Related]

  • 4. Preemption and medical devices: a response to Adler and Mann.
    Hermann M, Ritts GJ.
    Food Drug Law J; 1996 Dec 17; 51(1):1-19. PubMed ID: 11794345
    [Abstract] [Full Text] [Related]

  • 5. Preemption of the "fraud on the FDA" exception to Michigan's tort immunity statute for drug manufacturers: reconsidering Garcia and Desiano after Levine.
    Murdey J.
    Food Drug Law J; 2011 Dec 17; 66(1):85-104, ii-iii. PubMed ID: 24505848
    [Abstract] [Full Text] [Related]

  • 6. The Safe Medical Devices Act of 1990--FDA. Notice.
    Fed Regist; 1991 Apr 05; 56(66):14111-3. PubMed ID: 10111151
    [Abstract] [Full Text] [Related]

  • 7. Medical devices; device tracking--FDA. Final rule; suspension of effective date; notification of status under the Safe Medical Devices Act; technical amendments.
    Fed Regist; 1993 Aug 16; 58(156):43442-51. PubMed ID: 10127886
    [Abstract] [Full Text] [Related]

  • 8. Permitting product liability litigation for FDA-approved drugs and devices promotes patient safety.
    Kesselheim AS.
    Clin Pharmacol Ther; 2010 Jun 16; 87(6):645-7. PubMed ID: 20485322
    [Abstract] [Full Text] [Related]

  • 9. Medical devices; procedures for premarket notification, premarket approval, classification, performance standards establishment, banning devices, and availability of regulatory hearings--FDA. Final rule.
    Fed Regist; 1992 Dec 10; 57(238):58400-6. PubMed ID: 10123143
    [Abstract] [Full Text] [Related]

  • 10. Exemption from federal preemption of state and local cigarette and smokeless tobacco requirements; revocation. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Nov 07; 65(216):66636. PubMed ID: 11503697
    [Abstract] [Full Text] [Related]

  • 11. Medical devices; exemption from premarket notification and reserved devices; Class I--FDA. Proposed rule.
    Fed Regist; 1998 Nov 12; 63(218):63222-53. PubMed ID: 10187398
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Premarket approval and federal preemption of product liability claims in the wake of Medtronic, Inc. v. Lohr.
    Jarcho DG.
    Food Drug Law J; 1996 Nov 12; 51(4):613-8. PubMed ID: 11797730
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Medical devices; establishment registration and device listing for manufacturers and distributors of devices; companion to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 Sep 29; 63(188):51874-5. PubMed ID: 10185813
    [Abstract] [Full Text] [Related]

  • 18. Device tracking: user facility responsibilities.
    Shepherd N.
    J Clin Eng; 1993 Sep 29; 18(5):441-52. PubMed ID: 10129809
    [Abstract] [Full Text] [Related]

  • 19. Medical devices; exemption from premarket notification and reserved devices; class I. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Jan 14; 65(10):2296-323. PubMed ID: 11010655
    [Abstract] [Full Text] [Related]

  • 20. Biological products regulated under Section 351 of the Public Health Services Act; implementation of biologics license; elimination of establishment license and product license; correction--FDA. Proposed rule; correction.
    Fed Regist; 1998 Sep 02; 63(170):46718. PubMed ID: 10182705
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.